Date: 2013-05-31
Type of information: Collaboration agreement
Compound:
Company: The Cell Therapy Catapult (UK) The Centre for Commercialization of Regenerative Medicine (CCRM) (Canada)
Therapeutic area: Regenerative medicine
Type agreement: collaboration
Action mechanism: cell therapy
Disease:
Details: * On May 31, 2013, the Centre for Commercialization of Regenerative Medicine (CCRM) and the Cell Therapy Catapult , government-funded translation centres in Canada and the UK respectively, have signed a collaboration agreement solidifying their intent to work together. The partners will support the development and commercialization of cell therapy and regenerative medicine opportunities from the high impact technological discoveries emerging in their respective countries.
Under the terms of their agreement, CCRM and the Cell Therapy Catapult plan to work together on suitable R&D projects, clinical trials, standardization and regulatory efforts, as well as initiatives such as training.
The governments in Canada and the UK have identified the field of cell therapy and regenerative medicine for its potential ability to increase each nation’s health and wealth. CCRM and the Cell Therapy Catapult are centres of excellence that are well aligned to deliver on this potential.
Financial terms:
Latest news:
